USA: The use of Impella during the high-risk percutaneous coronary intervention (PCI) led to improved survival and less in-hospital myocardial infarction (MI) and cardiogenic shock compared with an.
Jaipur (Rajasthan) [India], October 6 (ANI/BusinessWire India): Madan Mohan Khandelwal (86), who was suffering from poor pumping capacity of the heart and severe calcified heart blockages could not be operated through angioplasty nor was bypass surgery possible due to his age and multiple co-morbidities
Abiomed (ABMD) announces the result of a three-year, investigator-led study of all Impella-supported patients treated at 109 hospitals in Japan shows a 30-day survival rate of 77% for patients with